Results 291 to 300 of about 850,017 (337)

State‐of‐the‐Art Strategies for Circular RNA in Cancers: Opportunity and Challenge

MedComm, Volume 7, Issue 2, February 2026.
Overview of circular RNA in tumors. ABSTRACT Circular RNAs (circRNAs) are characterized by their covalently closed structure, remarkable stability, and precise spatiotemporal regulation, evolving from once‐overlooked transcriptional byproducts to pivotal molecular regulators.
Zehao Ding, Zai Luo, Liao Zhang, Shaopeng Zhang, Renchao Zhang, Zhengjun Qiu, Chen Huang   +6 more
wiley   +1 more source

Development of a Cellular Membrane Nanovesicle-Based Vaccine Against Porcine Epidemic Diarrhea Virus. [PDF]

Cells
Wang X, Zhang W, Hu H, Gao W, Ma X, Wu Y, Qiao Y, Wang Y, Zhang D, Dong C, Wang H, Liu Z.   +11 more
europepmc   +1 more source

[Inactivated polio vaccine].

Atencion primaria, 2005
openaire   +1 more source

An mRNA Vaccine Based on Antigens From Conserved Regions of Monkeypox Virus A35R and M1R With a Dimer‐Like Conformation Confers Protection Against Both Monkeypox Virus and Vaccinia Virus Infections in Mice

MedComm, Volume 7, Issue 2, February 2026.
We developed four candidate mRNA vaccine antigens based on conserved sequences of MPXV A35R and M1R proteins. Our findings demonstrate that the MV2 vaccine possesses favorable immunogenicity and prophylactic potential against MPXV and VACV infections, positioning it as a promising clinical candidate for MPXV prevention.
Cong Tang, Longhai Yuan, Yun Xie, Yun Yang, Yanan Zhou, Junbing Wang, Hao Yang, Rui Peng, Jiali Xu, Wenhai Yu, Qing Huang, Wenqi Quan, Baisheng Li, Youchun Wang, Shuaiyao Lu   +14 more
wiley   +1 more source

Applying principles of vaccine development to oncomicrobial vaccines. [PDF]

Blood Adv
Despins CA, Viegas NJP, Holt RA.
europepmc   +1 more source

An updated review of Zika virus vaccine development. [PDF]

Clin Exp Vaccine Res
Lee HJ, Abu Bakar S, Shin OS.
europepmc   +1 more source

Development and evaluation of an experimental inactivated vaccine against lumpy skin disease. [PDF]

Vet World
Shahzad A, Shahzad W, Arshad MI, Abbas RZ, Mahmood MS.   +4 more
europepmc   +1 more source

A Chemically Induced Vibrio harveyi Bacterial Ghost Vaccine Confers Enhanced Protection in Turbot (Scophthalmus maximus). [PDF]

Vaccines (Basel)
Lv H, Yang J, Yu R, Liu Q, Liu X.
europepmc   +1 more source

Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain. [PDF]

Vaccines (Basel)
Nikiforova MA, Gushchin VA, Kleymenov DA, Kocherzhenko AM, Bykonia EN, Mazunina EP, Kozlova SR, Russu LI, Kuznetsova NA, Shidlovskaya EV, Marchuk EV, Usachev EV, Usacheva OV, Shcheblyakov DV, Kozlova IV, Tkachev SE, Pochtovyi AA, Zlobin VI, Logunov DY, Gintsburg AL.   +19 more
europepmc   +1 more source

Immune responses after two inactivated COVID-19 vaccine doses, a heterologous third dose and subsequent boosting with bivalent mRNA in adults. [PDF]

Sci Rep
Muangnoicharoen S, Lawpoolsri S, Cowan J, Luvira V, Jongkaewwattana A, Nanthapisal S, Phumratanaprapin W, Kamolratanakul S, Thanthamnu N, Duangdee C, Pitisuttithum P.   +10 more
europepmc   +1 more source